[Replay] EADV 2026 - What dermatologists need to know about the GLP-1 revolution?
Summary
Part 1 - GLP 1 What do we know today ?
9 min
Pr. B-M. PIRACCINI
Dermatologist, Italy
Part 2 - Results from an international survey on GLP-1 dermatologic impacts
13 min
Dr. B. HALIOUA
Dermatologist, France
Part 3 - Patients on GLP-1 Therapy: Understanding Dermatological Risk and Management Outcomes
10 min
Pr. B-M. PIRACCINI
Dermatologist, Italy
Part 4 - Questions and answers
8 min
Pr. B-M. PIRACCINI
Italy
Dr. B. HALIOUA
Dermatologist, France
Discover the scientific posters associated with this pathology
EADV2026_SKIN AND MUCOSAL SIDE EFFECTS OF GLP 1 RECEPTOR AGONISTS - A MULTINATIONAL CASE CONTROL STUDY
.PDF 0.43 Mo
EADV2026_DERMATOLOGICAL EFFECTS OF GLP1 RECEPTOR AGONISTS - AAD DENVER 2026 SURVEY
.PDF 0.21 Mo
Interested in our news?
Discover those of our other brands.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.